The DISARM Act Can Help Fix the Broken Antibiotics Market

In his a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly deteriorating antibiotics market and calls attention to the challenging ecosystem biopharmaceutical innovators and investors are having to deal with – or increasingly, moving away from altogether:
“The business model, the way we reimburse and pay for antibiotics, has just fundamentally crashed,” said Kevin Outterson, a Boston University law professor who has studied market fa